Wednesday, 17 Oct 2018

You are here

Erectile Dysfunction in Gout

The Journal of Rheumatology reports a population-based study demonstrating that gout is associated with an increased risk of developing erectile dysfunction (ED) suggesting that hyperuricemia and inflammation may be independent risk factors for ED.

Using an electronic medical record database in the United Kingdom, researchers did a matched cohort study comparing up to 5 control individuals (without gout) to each case of incident gout.  

They compared 38,438 gout patients (mean age 63.6 yrs) against 154,332 individuals without gout and found a higher rate of new ED cases in gout patients (11.9 vs 10.5 per 1000 person-years) compared to controls.

This translates to a roughly 15% increased risk of ED in gout patients.  The risk was even higher (31%) if the analysis was restricted to only gout patients receiving anti-gout treatment (n = 27,718).

The mechanisms by which gout or it's therapies could augment the risk of ED is not addressed by this population analyses. .

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Allopurinol Shown to be Renal Protective

Neogi and colleagues have shown that standard doses of allopurinol (300 mg/day) were associated with a 13% lower risk of renal function deterioration in chronic gout patients - thus, allopurinol does not appear to impair renal function over time.

Quarterly Canakinumab Reduces Gout Risk Without Affecting Uric Acid

The Annals of Internal Medicine reports that interleukin-1 (IL-1) inhibitor treatment is associated with a reduced risk of gout attacks - such are the findings of an anlysis of the CANTOS study previously reported at the Annual ACR 2017 meeting in Washington, DC. 

Usual Allopurinol Doses Insufficient in CKD Patients

Uric acid (sUA) control may be a challenge in patients with chronic kidney disease (CKD). A cohort study shows that conventional dosing recommendations for allopurinol are unlikely to reach target serum sUA goals.

Sleep Apnea Raises Gout Risk

Patients with obstructive sleep apnea were at increased risk for incident gout, particularly in the first years after the sleep apnea diagnosis, U.K. researchers reported.

In a large retrospective cohort study, the adjusted hazard ratio for a new gout diagnosis among individuals with sleep apnea was 1.42 (95% CI 1.29-1.56), according to Milica Blagojevic-Bucknall, PhD, of Keele University in Keele, England, and colleagues.

Adherence to Gout Therapies Painfully Low

A retrospective study of the large UK Clinical Practice Research Datalink assessed patient compliance in gout and found that adherence to allopurinol is poor, especially among females and younger patients and those with fewer comorbidities.